Literature DB >> 9445109

The role of radical gastrectomy with systematic lymphadenectomy for the diagnosis and treatment of primary gastric lymphoma.

Y Kodera1, Y Yamamura, S Nakamura, Y Shimizu, A Torii, T Hirai, K Yasui, T Morimoto, T Kato, T Kito.   

Abstract

OBJECTIVE: We evaluated the therapeutic efficacy of radical gastrectomy for primary B-cell lymphoma of the stomach and attempted to identify patients who could be adequately treated with surgery alone. SUMMARY BACKGROUND DATA: Several recent gastric lymphoma reports have discussed the therapeutic benefits of various treatment strategies for stage IE and IIE lymphoma. However, few studies have been based on patients accurately staged by systematic lymphadenectomy with subsequent pathologic examination.
METHODS: A retrospective study was performed to evaluate the survival and biologic behavior of lesions in 60 patients with gastric lymphoma who were treated by radical gastrectomy alone. Tumors were classified according to the histopathologic concept of mucosa-associated lymphoid tissue (MALT)-derived lymphoma.
RESULTS: A low histopathologic grade was associated with a significantly lower incidence of nodal metastasis (p = 0.07) and less extensive infiltration of the gastric wall (p < 0.005) despite larger tumor size. A 5-year survival rate of >95% was attained with surgery alone for MALT lymphoma and for true stage IE lymphoma diagnosed by pathologic examination of up to N2 lymph nodes routinely performed after radical gastrectomy.
CONCLUSIONS: Surgery alone is adequate treatment for stage IE or pure MALT lymphoma, provided that the staging is performed after radical gastrectomy.

Entities:  

Mesh:

Year:  1998        PMID: 9445109      PMCID: PMC1191171          DOI: 10.1097/00000658-199801000-00007

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  28 in total

Review 1.  Radical surgery for gastric cancer. A review of the Japanese experience.

Authors:  Y Noguchi; T Imada; A Matsumoto; D G Coit; M F Brennan
Journal:  Cancer       Date:  1989-11-15       Impact factor: 6.860

2.  A clinicopathologic study of 233 cases with special reference to evaluation with the MIB-1 index.

Authors:  S Nakamura; K Akazawa; T Yao; M Tsuneyoshi
Journal:  Cancer       Date:  1995-10-15       Impact factor: 6.860

3.  Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma.

Authors:  J Pedersen-Bjergaard; J Ersbøll; V L Hansen; B L Sørensen; K Christoffersen; K Hou-Jensen; N I Nissen; J B Knudsen; M M Hansen
Journal:  N Engl J Med       Date:  1988-04-21       Impact factor: 91.245

4.  Chemotherapy following surgery for stages IE and IIE non-Hodgkin's lymphoma of the gastrointestinal tract.

Authors:  F A Shepherd; W K Evans; G Kutas; J C Yau; P Dang; J G Scott; H A Farquharson; W H Francombe; D Bailey; M A Baker
Journal:  J Clin Oncol       Date:  1988-02       Impact factor: 44.544

5.  Has the incidence of primary gastric lymphoma increased?

Authors:  J Hayes; E Dunn
Journal:  Cancer       Date:  1989-05-15       Impact factor: 6.860

6.  Report of the Committee on Hodgkin's Disease Staging Classification.

Authors:  P P Carbone; H S Kaplan; K Musshoff; D W Smithers; M Tubiana
Journal:  Cancer Res       Date:  1971-11       Impact factor: 12.701

7.  Stomach conservation in stages IE and IIE gastric non-Hodgkin's lymphoma.

Authors:  M H Maor; W S Velasquez; L M Fuller; K B Silvermintz
Journal:  J Clin Oncol       Date:  1990-02       Impact factor: 44.544

8.  Immunoperoxidase technics in diagnostic pathology. Report of a workshop sponsored by the National Cancer Institute.

Authors:  R A DeLellis; L A Sternberger; R B Mann; P M Banks; P K Nakane
Journal:  Am J Clin Pathol       Date:  1979-05       Impact factor: 2.493

9.  Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents.

Authors:  J Pedersen-Bjergaard; J Ersbøll; H M Sørensen; N Keiding; S O Larsen; P Philip; M S Larsen; H Schultz; N I Nissen
Journal:  Ann Intern Med       Date:  1985-08       Impact factor: 25.391

10.  Primary gastric lymphoma.

Authors:  M S Hockey; J Powell; J Crocker; J W Fielding
Journal:  Br J Surg       Date:  1987-06       Impact factor: 6.939

View more
  10 in total

1.  Clinicopathologic features of surgically resected primary gastric lymphoma.

Authors:  Seong-Ho Kong; Min-A Kim; Do-Joong Park; Hyuk-Joon Lee; Hye-Seung Lee; Chul-Woo Kim; Han-Kwang Yang; Dae-Seog Heo; Kuhn-Uk Lee; Kuk-Jin Choe
Journal:  World J Gastroenterol       Date:  2004-04-15       Impact factor: 5.742

Review 2.  Synchronous and metachronous occurrence of gastric adenocarcinoma and gastric lymphoma: A review of the literature.

Authors:  Erhan Hamaloglu; Serdar Topaloglu; Arif Ozdemir; Ahmet Ozenc
Journal:  World J Gastroenterol       Date:  2006-06-14       Impact factor: 5.742

3.  Therapeutic comparison of chemotherapy and surgery for early stage diffuse large B-cell gastric lymphoma.

Authors:  Soo-Jeong Kim; June-Won Cheong; Jee Sook Hahn
Journal:  Yonsei Med J       Date:  2007-12-31       Impact factor: 2.759

Review 4.  Therapy of gastric mucosa associated lymphoid tissue lymphoma.

Authors:  Andrea Morgner; Renate Schmelz; Christian Thiede; Manfred Stolte; Stephan Miehlke
Journal:  World J Gastroenterol       Date:  2007-07-14       Impact factor: 5.742

Review 5.  The diminishing role of surgery in the treatment of gastric lymphoma.

Authors:  Sam S Yoon; Daniel G Coit; Carol S Portlock; Martin S Karpeh
Journal:  Ann Surg       Date:  2004-07       Impact factor: 12.969

Review 6.  Primary gastric lymphoma.

Authors:  Ahmad M Al-Akwaa; Neelam Siddiqui; Ibrahim A Al-Mofleh
Journal:  World J Gastroenterol       Date:  2004-01       Impact factor: 5.742

Review 7.  Surgical treatment of primitive gastro-intestinal lymphomas: a systematic review.

Authors:  Roberto Cirocchi; Eriberto Farinella; Stefano Trastulli; Davide Cavaliere; Piero Covarelli; Chiara Listorti; Jacopo Desiderio; Francesco Barberini; Nicola Avenia; Antonio Rulli; Giorgio Maria Verdecchia; Giuseppe Noya; Carlo Boselli
Journal:  World J Surg Oncol       Date:  2011-11-07       Impact factor: 2.754

8.  A case of Helicobactor pylori negative low-grade gastric MALT lymphoma in an elderly female, successfully treated with rituximab.

Authors:  Naba Raj Mainali; Madan Raj Aryal; Ravi Shahu Khal; Richard Alweis
Journal:  Am J Case Rep       Date:  2013-11-08

9.  The Impact of Surgery on Long-Term Survival of Patients with Primary Gastric Diffuse Large B-Cell Lymphoma: A SEER Population-Based Study.

Authors:  Ju-Li Lin; Jian-Xian Lin; Ping Li; Jian-Wei Xie; Jia-Bin Wang; Jun Lu; Qi-Yue Chen; Long-Long Cao; Chao-Hui Zheng; Chang-Ming Huang
Journal:  Gastroenterol Res Pract       Date:  2019-02-24       Impact factor: 2.260

Review 10.  Unusual Complicated Gastric Ulcers.

Authors:  Mircea Nicolae Brătucu; Virgiliu-Mihail Prunoiu; Victor Strâmbu; Eugen Brătucu; Maria-Manuela Răvaş; Laurenţiu Simion; Radu Petre
Journal:  Medicina (Kaunas)       Date:  2021-12-09       Impact factor: 2.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.